Cargando…
Targeting of two aspects of metabolism in breast cancer treatment
Deregulated metabolism is gaining recognition as a hallmark of cancer cells, and is being explored for therapeutic potential. The Warburg effect is a metabolic phenotype that occurs in 90% of tumors, where glycolysis is favored despite the presence of oxygen. Dichloroacetate (DCA) is a pyruvate dehy...
Autores principales: | Gang, Bevan P, Dilda, Pierre J, Hogg, Phillip J, Blackburn, Anneke C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622508/ https://www.ncbi.nlm.nih.gov/pubmed/25482950 http://dx.doi.org/10.4161/15384047.2014.955992 |
Ejemplares similares
-
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
por: Sun, Ramon C, et al.
Publicado: (2011) -
The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas
por: Wang, Xiaochun, et al.
Publicado: (2020) -
Dual-targeting of aberrant glucose metabolism in glioblastoma
por: Shen, Han, et al.
Publicado: (2015) -
The tumour metabolism inhibitors GSAO and PENAO react with cysteines 57 and 257 of mitochondrial adenine nucleotide translocase
por: Park, Danielle, et al.
Publicado: (2012) -
Glutathione S-conjugates as prodrugs to target drug-resistant tumors
por: Ramsay, Emma E., et al.
Publicado: (2014)